Concepts (197)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinoids | 7 | 2021 | 25 | 2.690 |
Why?
|
| Hypervitaminosis A | 4 | 2019 | 4 | 1.550 |
Why?
|
| Autistic Disorder | 3 | 2019 | 39 | 1.460 |
Why?
|
| Vitamin A | 8 | 2019 | 86 | 1.410 |
Why?
|
| Liver Diseases | 2 | 2021 | 34 | 1.290 |
Why?
|
| Rubella | 2 | 2019 | 16 | 1.220 |
Why?
|
| Burkitt Lymphoma | 2 | 2017 | 25 | 1.070 |
Why?
|
| Terrorism | 2 | 2023 | 13 | 1.050 |
Why?
|
| Disasters | 3 | 2023 | 79 | 1.020 |
Why?
|
| Malaria, Falciparum | 2 | 2017 | 90 | 0.850 |
Why?
|
| Transsexualism | 1 | 2024 | 20 | 0.830 |
Why?
|
| Herpesvirus 4, Human | 2 | 2017 | 36 | 0.670 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2017 | 20 | 0.660 |
Why?
|
| Aggression | 2 | 2013 | 102 | 0.650 |
Why?
|
| Rubella Syndrome, Congenital | 1 | 2019 | 2 | 0.630 |
Why?
|
| Mumps | 1 | 2019 | 3 | 0.620 |
Why?
|
| Measles | 1 | 2019 | 7 | 0.620 |
Why?
|
| Sex Education | 1 | 2019 | 36 | 0.610 |
Why?
|
| Pregnancy in Adolescence | 1 | 2019 | 34 | 0.600 |
Why?
|
| Liver | 4 | 2019 | 511 | 0.600 |
Why?
|
| Persian Gulf Syndrome | 1 | 2019 | 4 | 0.590 |
Why?
|
| School Health Services | 1 | 2019 | 90 | 0.570 |
Why?
|
| Humans | 32 | 2024 | 43102 | 0.540 |
Why?
|
| Stuttering | 1 | 2016 | 5 | 0.510 |
Why?
|
| Plasmodium falciparum | 2 | 2017 | 144 | 0.470 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2015 | 3 | 0.450 |
Why?
|
| Motor Vehicles | 1 | 2014 | 14 | 0.440 |
Why?
|
| Health Services Needs and Demand | 4 | 2024 | 154 | 0.440 |
Why?
|
| Automobile Driving | 1 | 2014 | 25 | 0.430 |
Why?
|
| Accidents, Traffic | 1 | 2014 | 48 | 0.430 |
Why?
|
| Leukocytes | 2 | 2011 | 80 | 0.420 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2013 | 1 | 0.410 |
Why?
|
| Psychoses, Substance-Induced | 1 | 2013 | 2 | 0.410 |
Why?
|
| Mefloquine | 1 | 2013 | 4 | 0.410 |
Why?
|
| Health Surveys | 1 | 2015 | 405 | 0.400 |
Why?
|
| Depression, Postpartum | 1 | 2013 | 16 | 0.390 |
Why?
|
| Models, Biological | 2 | 2013 | 712 | 0.390 |
Why?
|
| Dengue Virus | 1 | 2013 | 96 | 0.370 |
Why?
|
| Erythrocytes | 1 | 2013 | 126 | 0.370 |
Why?
|
| Violence | 2 | 2023 | 136 | 0.360 |
Why?
|
| Breast Feeding | 1 | 2013 | 126 | 0.360 |
Why?
|
| Wounds, Gunshot | 1 | 2011 | 30 | 0.330 |
Why?
|
| Atherosclerosis | 1 | 2011 | 169 | 0.310 |
Why?
|
| Brain Injuries | 1 | 2011 | 129 | 0.290 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2011 | 193 | 0.290 |
Why?
|
| Ascorbic Acid Deficiency | 1 | 2008 | 3 | 0.290 |
Why?
|
| Exanthema | 1 | 2008 | 12 | 0.290 |
Why?
|
| Bone Diseases | 1 | 2008 | 18 | 0.280 |
Why?
|
| Growth Disorders | 1 | 2008 | 23 | 0.280 |
Why?
|
| Brain | 1 | 2016 | 1472 | 0.280 |
Why?
|
| Respiratory Tract Infections | 1 | 2008 | 36 | 0.280 |
Why?
|
| Heart Rate | 1 | 2008 | 266 | 0.260 |
Why?
|
| Child | 5 | 2016 | 3443 | 0.260 |
Why?
|
| Vaccination | 2 | 2019 | 355 | 0.250 |
Why?
|
| Female | 10 | 2024 | 24698 | 0.240 |
Why?
|
| Child, Preschool | 3 | 2016 | 1546 | 0.230 |
Why?
|
| Pregnancy | 4 | 2019 | 1772 | 0.230 |
Why?
|
| Mass Behavior | 1 | 2005 | 2 | 0.230 |
Why?
|
| Pain | 1 | 2008 | 290 | 0.220 |
Why?
|
| Malaria | 2 | 2017 | 90 | 0.220 |
Why?
|
| Panic Disorder | 1 | 2005 | 102 | 0.210 |
Why?
|
| Social Behavior | 1 | 2005 | 161 | 0.200 |
Why?
|
| Protective Devices | 1 | 2002 | 3 | 0.190 |
Why?
|
| Risk Factors | 3 | 2019 | 3994 | 0.190 |
Why?
|
| Automobiles | 1 | 2002 | 6 | 0.190 |
Why?
|
| Onchocerciasis | 1 | 2002 | 7 | 0.190 |
Why?
|
| Total Quality Management | 1 | 2002 | 11 | 0.190 |
Why?
|
| Security Measures | 1 | 2002 | 3 | 0.190 |
Why?
|
| Social Control Policies | 1 | 2002 | 4 | 0.190 |
Why?
|
| Infant, Newborn | 3 | 2013 | 972 | 0.190 |
Why?
|
| Managed Care Programs | 1 | 2002 | 40 | 0.180 |
Why?
|
| Evidence-Based Medicine | 1 | 2002 | 107 | 0.180 |
Why?
|
| Cesarean Section | 1 | 2002 | 63 | 0.180 |
Why?
|
| Firearms | 1 | 2002 | 16 | 0.180 |
Why?
|
| Epidemiology | 1 | 2002 | 9 | 0.180 |
Why?
|
| Pre-Eclampsia | 1 | 2003 | 67 | 0.180 |
Why?
|
| Fear | 1 | 2005 | 272 | 0.180 |
Why?
|
| Hot Temperature | 1 | 2002 | 141 | 0.180 |
Why?
|
| Infant | 3 | 2013 | 1175 | 0.180 |
Why?
|
| Adolescent | 4 | 2019 | 6081 | 0.180 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2003 | 229 | 0.180 |
Why?
|
| Male | 7 | 2024 | 23409 | 0.180 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2003 | 117 | 0.170 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 259 | 0.170 |
Why?
|
| Mississippi | 2 | 2019 | 129 | 0.170 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 64 | 0.170 |
Why?
|
| Liver Cirrhosis | 1 | 2021 | 67 | 0.160 |
Why?
|
| Schools | 1 | 2002 | 283 | 0.160 |
Why?
|
| Rubella virus | 1 | 2019 | 12 | 0.150 |
Why?
|
| Pyridostigmine Bromide | 1 | 2019 | 6 | 0.150 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2019 | 44 | 0.140 |
Why?
|
| Blood Pressure | 2 | 2011 | 666 | 0.130 |
Why?
|
| HIV-1 | 1 | 2003 | 755 | 0.130 |
Why?
|
| Veterans | 1 | 2019 | 210 | 0.120 |
Why?
|
| Environmental Exposure | 1 | 2019 | 256 | 0.120 |
Why?
|
| Health Promotion | 1 | 2002 | 704 | 0.120 |
Why?
|
| B-Lymphocytes | 1 | 2017 | 189 | 0.120 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2015 | 9 | 0.110 |
Why?
|
| Cholestasis | 1 | 2015 | 12 | 0.110 |
Why?
|
| Epidermis | 1 | 2015 | 23 | 0.110 |
Why?
|
| India | 1 | 2015 | 108 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2019 | 1759 | 0.110 |
Why?
|
| Keratinocytes | 1 | 2015 | 67 | 0.110 |
Why?
|
| Arabs | 2 | 2012 | 19 | 0.110 |
Why?
|
| Safety | 1 | 2014 | 54 | 0.110 |
Why?
|
| Mastitis | 1 | 2013 | 2 | 0.100 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 146 | 0.100 |
Why?
|
| Skin | 1 | 2015 | 187 | 0.100 |
Why?
|
| Public Health | 3 | 2010 | 424 | 0.100 |
Why?
|
| Antifungal Agents | 1 | 2015 | 169 | 0.100 |
Why?
|
| Hemolysis | 1 | 2013 | 60 | 0.100 |
Why?
|
| Milk | 1 | 2013 | 56 | 0.100 |
Why?
|
| Oxidoreductases | 1 | 2013 | 79 | 0.100 |
Why?
|
| Mother-Child Relations | 1 | 2013 | 64 | 0.100 |
Why?
|
| Hospitals, Public | 1 | 2012 | 14 | 0.100 |
Why?
|
| Anemia | 1 | 2013 | 55 | 0.100 |
Why?
|
| Tretinoin | 1 | 2013 | 50 | 0.100 |
Why?
|
| Hospital Costs | 1 | 2012 | 27 | 0.100 |
Why?
|
| Endocytosis | 1 | 2013 | 118 | 0.090 |
Why?
|
| Adult | 4 | 2013 | 13872 | 0.090 |
Why?
|
| Premature Birth | 1 | 2013 | 95 | 0.090 |
Why?
|
| Rural Population | 1 | 2015 | 373 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 694 | 0.090 |
Why?
|
| Animals | 4 | 2013 | 16992 | 0.090 |
Why?
|
| Creatinine | 1 | 2011 | 102 | 0.090 |
Why?
|
| Glomerular Filtration Rate | 1 | 2011 | 147 | 0.090 |
Why?
|
| Israel | 1 | 2011 | 21 | 0.090 |
Why?
|
| Lymphocytes | 1 | 2011 | 124 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 432 | 0.080 |
Why?
|
| Medical Record Linkage | 1 | 2011 | 17 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2010 | 32 | 0.080 |
Why?
|
| Neutrophils | 1 | 2011 | 145 | 0.080 |
Why?
|
| Career Choice | 1 | 2010 | 52 | 0.080 |
Why?
|
| Aged | 3 | 2011 | 8214 | 0.080 |
Why?
|
| Health Services Research | 1 | 2010 | 161 | 0.080 |
Why?
|
| Monocytes | 1 | 2011 | 277 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2012 | 380 | 0.070 |
Why?
|
| Mythology | 1 | 2008 | 2 | 0.070 |
Why?
|
| Social Alienation | 1 | 2008 | 4 | 0.070 |
Why?
|
| Relief Work | 1 | 2008 | 6 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 1067 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2008 | 42 | 0.070 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2008 | 65 | 0.070 |
Why?
|
| Incidence | 1 | 2011 | 1078 | 0.070 |
Why?
|
| HIV Infections | 1 | 2003 | 2586 | 0.070 |
Why?
|
| Vitamins | 1 | 2008 | 81 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2008 | 138 | 0.070 |
Why?
|
| Disaster Planning | 1 | 2008 | 62 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2012 | 2544 | 0.070 |
Why?
|
| Middle Aged | 3 | 2011 | 12222 | 0.070 |
Why?
|
| Apoptosis | 1 | 2015 | 1568 | 0.060 |
Why?
|
| Family | 1 | 2008 | 195 | 0.060 |
Why?
|
| United States | 4 | 2010 | 5205 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2008 | 549 | 0.060 |
Why?
|
| Residence Characteristics | 1 | 2008 | 363 | 0.060 |
Why?
|
| Minority Groups | 1 | 2010 | 690 | 0.060 |
Why?
|
| Psychology | 1 | 2005 | 39 | 0.060 |
Why?
|
| Terminally Ill | 1 | 2003 | 4 | 0.050 |
Why?
|
| Patents as Topic | 1 | 2003 | 14 | 0.050 |
Why?
|
| Sample Size | 1 | 2003 | 28 | 0.050 |
Why?
|
| Accident Prevention | 1 | 2002 | 8 | 0.050 |
Why?
|
| Onchocerca volvulus | 1 | 2002 | 5 | 0.050 |
Why?
|
| Ivermectin | 1 | 2002 | 3 | 0.050 |
Why?
|
| Unnecessary Procedures | 1 | 2002 | 12 | 0.050 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2002 | 6 | 0.050 |
Why?
|
| Information Services | 1 | 2002 | 13 | 0.050 |
Why?
|
| Health Services Misuse | 1 | 2002 | 20 | 0.050 |
Why?
|
| Diet | 1 | 2008 | 826 | 0.050 |
Why?
|
| Education, Medical, Continuing | 1 | 2002 | 35 | 0.050 |
Why?
|
| Anthelmintics | 1 | 2002 | 23 | 0.050 |
Why?
|
| Safety Management | 1 | 2002 | 17 | 0.050 |
Why?
|
| Mice | 1 | 2013 | 6644 | 0.050 |
Why?
|
| Criminal Law | 1 | 2002 | 28 | 0.050 |
Why?
|
| Juvenile Delinquency | 1 | 2002 | 44 | 0.040 |
Why?
|
| Social Justice | 1 | 2002 | 65 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2002 | 193 | 0.040 |
Why?
|
| Young Adult | 1 | 2011 | 5080 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2005 | 661 | 0.040 |
Why?
|
| Systole | 1 | 2010 | 67 | 0.020 |
Why?
|
| Diastole | 1 | 2010 | 47 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2010 | 490 | 0.020 |
Why?
|
| Mentors | 1 | 2010 | 145 | 0.020 |
Why?
|
| Peer Group | 1 | 2010 | 177 | 0.020 |
Why?
|
| Survival | 1 | 2008 | 8 | 0.020 |
Why?
|
| Foreign Medical Graduates | 1 | 2008 | 4 | 0.020 |
Why?
|
| Anxiety, Separation | 1 | 2008 | 4 | 0.020 |
Why?
|
| Louisiana | 1 | 2008 | 50 | 0.020 |
Why?
|
| International Cooperation | 1 | 2008 | 52 | 0.020 |
Why?
|
| Water Supply | 1 | 2008 | 60 | 0.020 |
Why?
|
| Curriculum | 1 | 2010 | 318 | 0.020 |
Why?
|
| Housing | 1 | 2008 | 74 | 0.020 |
Why?
|
| Food Supply | 1 | 2008 | 122 | 0.020 |
Why?
|
| Vulnerable Populations | 1 | 2008 | 166 | 0.020 |
Why?
|
| Texas | 1 | 2008 | 457 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2010 | 1600 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2010 | 590 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2010 | 3156 | 0.010 |
Why?
|